samedan logo

 
 
spacer
home > white papers > Customising the Cold Chain - World Courier
WHITE PAPERS
logo_World_Cour5.JPEG

World Courier

phone +44 (0)20 7928 7256
email marketing@worldcourier.com
web http://www.worldcourier.com
email 12th Floor, 25 Farringdon Street, London, EC4A4AB

Customising the Cold Chain

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

AirBridgeCargo Airlines Expands Its Partnership With Sonoco Thermosafe To Embrace New Pegasus Uld Passive Container

AirBridgeCargo Airlines, part of Volga-Dnepr Group, expands its Master Lease Agreement with Sonoco ThermoSafe to enable its customers worldwide to transport life-saving and healthcare products within Pegasus ULD passive container (passive container – ULD capable to maintain internal temperature environment during a certain period of time without charge). The latest Sonoco addition to a sophisticated product family will guarantee secure, trackable, and reliable transportation of temperature-sensitive pharmaceutical shipments of up to 998 kg.
More info >>


White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>


Industry Events

DIA Europe 2021

15-19 March 2021, VIRTUAL CONFERENCE

DIA Europe is the must-attend event for all life science professionals working in drug development, from discovery to marketed use. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial discussions across several topic tracks: Clinical Development, Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy, and many more.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement